Published January 23, 2024 | Version online
Journal article Open

Nicotine Replacement therapy

Authors/Creators

  • 1. Senior Resident1
  • 2. Professor2
  • 3. Associate Professor3
  • 4. Reader4
  • 5. Senior Resident5
  • 6. Senior Resident6

Description

In 1980, a pivotal moment occurred in the field of mental health with the inclusion of "nicotine dependence" in the third edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM).Tobacco dependence is defined as, “Cluster of behavioural, cognitive and physiological phenomena that develop after repeated tobacco use and that typically include a strong desire to use tobacco, difficulties in controlling its use, persistence in tobacco use despite harmful consequences, a higher priority given to tobacco use than other activities and obligations, increased tolerance and sometimes a physical withdrawal state.”4Both smoked and smokeless forms of tobacco contain nicotine, a highly addictive chemical, making it difficult for habituated tobacco users to quit.Google Scholar was utilized to take an initial sample of what types of articles are available. We searched other databases like PubMed, EMBASE, COCHRANE LIBRARY for research articles published up to March, 2023 with no language restrictions. NRT is relatively unlikely to help smokers who are not motivated to quit or do notexperience or expect to experience nicotine withdrawal symptoms.The Nicotine Replacement Therapy helps by timely delivering pure nicotine, and therefore poses less riskand reduces cravings. Several nicotine medications are available in different forms, doses and flavours.

Files

review article on nicotine replacement therapy.pdf

Files (992.3 kB)

Additional details

References

  • 1. WHO. The ICD-10 Classification Of Mental And Behavioural Disorders: Diagnostic Criteria For Research F10–F19. Available www.Who. Int/ Substance Abuse/ Terminology/ ICD10 Research Diagnosis. Pdf. Accessed May 15, 2011. 2. Goyal SK, Biswal PC, Ranganathan KV. Economic history of tobacco production in India. Institute for Studies in Industrial Development, New Delhi. pp. 2004:1-6. 3. Watkins SS, Koob GF, Markou A. Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine & Tobacco Research. 2000 Feb 1;2(1):19-37. 4. Fiore MC. US public health service clinical practice guideline: treating tobacco use and dependence. Respiratory care. 2000 Oct;45(10):1200-62. 5. Zaveri NT, Rollema H, Swan GE. Nicotine Dependence. InThe Tobacco Epidemic 2015 (Vol. 42, pp. 47-57). Karger Publishers. 6. Wiebel FJ. Chemistry and primary toxicity of tobacco and tobacco smoke. InThe Tobacco Epidemic 2015 (Vol. 42, pp. 37-46). Karger Publishers 7. Clancy L, Kabir Z. Health Effects of Passive Smoking in Adults. InThe Tobacco Epidemic 2015 (Vol. 42, pp. 110-120). Karger Publishers.2 8. Molyneux A. Nicotine replacement therapy. Bmj. 2004 Feb 19;328(7437):454-6. 9. Tønnesen P. Pharmacotherapy: Nicotine replacement therapy and other drugs in smoking cessation (including vaccination). InThe Tobacco Epidemic 2015 (Vol. 42, pp. 229-242). Karger Publishers. 10. Kamala KA, Sankethguddad S, Sujith SG. An update on nicotine replacement therapy. Journal of Oral Research and Review. 2019 Jan 1;11(1):41. 11. Ravi S, Sharma PK, Bansal M. Review: Transdermal Drug Delivery of Nicotine. Int J Drug Dev Res. 2011 Apr;3:01-8. 12. Wadgave U, Nagesh L. Nicotine replacement therapy: an overview. International journal of health sciences. 2016 Jul;10(3):425. 13. Sumana CK, Nagaraj T, Nigam H, Gogula S, Saxena S. Nicotine replacement therapy: A review. Journal of Medicine, Radiology, Pathology and Surgery. 2018;5(1):6-8. 14. Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, Sherman SE, Cleveland M, Antonuccio DO, Hartman N, McGovern PG. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. New England Journal of Medicine. 1996 Dec 12;335(24):1792-8. 15. Aslani A, Rafiei S. Design, formulation and evaluation of nicotine chewing gum. Advanced biomedical research. 2012;1. 16. Molander L, Lunell E, Fagerstrom KO. Reduction of tobacco withdrawal symptoms with a sublingual nicotine tablet: a placebo controlled study. Nicotine & tobacco research. 2000 May 1;2(2):187-91 17. Glover ED, Glover PN, Franzon M, Sullivan CR, Cerullo CC, Howell RM, Keyes GG, Nilsson F, Hobbs GR. A comparison of a nicotine sublingual tablet and placebo for smoking cessation. Nicotine & tobacco research. 2002 Nov 1;4(4):441-50. 18. Orleans CT, Slade J, Slade JD, editors. Nicotine addiction: principles and management. Oxford University Press on Demand; 1993. 19. Wallström M, Nilsson F, Hirsch JM. A randomized, double‐blind, placebo‐controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation. Addiction. 2000 Aug;95(8):1161-71. 20. Nides M, Danielsson T, Saunders F, Perfekt R, Kapikian R, Solla J, Leischow SJ, Myers A. Efficacy and Safety of a Nicotine Mouth Spray for Smoking Cessation: A Randomized, Multicentre, Controlled Study in a Naturalistic Setting. Nicotine & Tobacco Research. 2018 Nov 18. 21. Tønnesen P, Lauri H, Perfekt R, Mann K, Batra A. Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial. European Respiratory Journal. 2012 Sep 1;40(3):548-54. 22. Nides M, Danielsson T, Saunders F, Perfekt R, Kapikian R, Solla J, Leischow SJ, Myers A. Efficacy and Safety of a Nicotine Mouth Spray for Smoking Cessation: A Randomized, Multicentre, Controlled Study in a Naturalistic Setting. Nicotine & Tobacco Research. 2018 Nov 18. 23. Gupta R, Bharat A, Dhiman U, Sharma A. Nicotine replacement therapy: A smoking cessation aid… an overview. 24. Drummond MB, Upson D. Electronic cigarettes. Potential harms and benefits. Annals of the American Thoracic Society. 2014 Feb;11(2):236-42. 25. Chang PH, Chiang CH, Ho WC, Wu PZ, Tsai JS, Guo FR. Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials. BMC public health. 2015 Dec;15(1):689.